EXAS

EXAS

USD

Exact Sciences Corporation Common Stock

$69.590-0.480 (-0.685%)

السعر في الوقت الحقيقي

Healthcare
Diagnostics & Research
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$70.070

الأعلى

$72.810

الأدنى

$67.970

الحجم

1.54M

أساسيات الشركة

القيمة السوقية

13.2B

الصناعة

Diagnostics & Research

البلد

United States

إحصاءات التداول

متوسط الحجم

2.95M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $38.81الحالي $69.590الأعلى $72.83

أخبار ذات صلة

Analyst Upgrades

TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90

TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.

عرض المزيد
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
Analyst Upgrades

Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88

Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.

عرض المزيد
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Analyst Upgrades

Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75

Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.

عرض المزيد
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75

Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.

عرض المزيد
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77

Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.

عرض المزيد
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Analyst Upgrades

Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80

Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.

BusinessWire

Exact Sciences to Participate in November Investor Conference

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.